China Chinese Patent Medicine Industry Report, 2012-2015

NEW YORK, April 22, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

China Chinese Patent Medicine Industry Report, 2012-2015

http://www.reportlinker.com/p0361703/China-Chinese-Patent-Medicine-Industry-Report-2012-2015.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication

In recent years, China's Chinese patent medicine industry has been running in good condition, with the revenue increasing from RMB 142 billion in 2008 to RMB 360 billion in 2012 at a CAGR of 26.2%. Over the same period, the total profit maintained a CAGR of 26.6%, and the gross margin remained higher than the average level of the overall pharmaceutical industry.

In succession to the Opinions on Promoting the Development of Traditional Chinese Medicine Services and Trade, the Twelfth Five-Year Plan on the Development of Traditional Chinese Medicine and other favorable policies, the new National Essential Drugs List published in March 2013 increased the number of Chinese patent medicine from 102 in 2009 to 203, and the proportion in total quantity from 33% to 39%. As a result, China's Chinese patent medicine market demand is expected to grow rapidly in the next five years.

Chinese patent medicine for the treatment of cardiovascular and cerebrovascular diseases, tumor diseases, respiratory system diseases, musculoskeletal diseases and digestive system diseases are top five categories of Chinese patent medicine for hospitals in China. The Chinese patent medicine for the treatment of cardiovascular and cerebrovascular diseases occupies the largest market share, which remained at around 37% in 2006-2012. Outstanding enterprises producing Chinese patent medicine for the treatment of cardiovascular and cerebrovascular diseases include Shandong Buchang Pharma (products include Guanxin Shutong Capsule and Naoxinshu Oral Solution), Tianjin Tasly Group (products include Compound Danshen Dripping Pills and Yangxue Qingnao Granule), J Pharmaceutical (products include Mailuoning Injection and Mailuoning Oral Solution), Shijiazhuang Yiling Pharmaceutical (products include Tongxinluo Capsule and Shensong Yangxin Capsule), etc.

As China's Chinese patent medicine is gaining international recognition, coupled with the incentive from high profit (the operating margin is generally above 70%) and the development bottleneck of the chemical pharmaceutical industry, foreign enterprises and institutions such as Novartis, Merck, Johnson & Johnson, GSK have set foot in the Chinese patent medicine market through joint ventures and wholly-owned subsidiaries. For example, in early 2013, GSK announced to carry out drug development trying to use traditional Chinese medicinal ingredients in China.

China Chinese Patent Medicine Industry Report, 2012-2015 of ResearchInChina mainly includes the following contents:

Industrial policies, development status, regional market, import and export, development trend of China's Chinese patent medicine industry; Development status of the raw material market of China's Chinese patent medicine industry as well as the development status and import & export of China's plant extracts; China's Chinese patent medicine market segments, including Chinese patent medicine for the treatment of cardiovascular and cerebrovascular diseases, tumor diseases, respiratory system diseases, etc.; Operation, revenue structure, gross margin and profit forecast of China's 10 major Chinese patent medicine production enterprises.

Table of Contents

1.1 Definition and Features

1.2 Classification

1.2.1 Classification by Dosage Form

1.2.2 Classification by Pharmacology

1.2.3 Industry Chain

2. Operating Environment for Chinese Patent Medicine Industry2.1 Policies 2.1.1 Domestic Policies 2.1.2 Foreign Policies 2.2 Consumption Trend2.3 Industry Trend

3. Market of Chinese Patent Medicine Industry

3.1 Development Status

3.2 Supply and Demand

3.2.1 Supply

3.2.2 Demand

3.3 Regional Market

3.4 Import and Export

3.4.1 Export

3.4.2 Import

3.5 Demand Trend

3.5.1 Overview of Pharmaceutical Demand

3.5.2 Population Aging Promotes Market Demand of Pharmaceutical Industry

3.5.3 Urbanization Increases Healthcare Market Demand

3.5.4 Disease Trend

3.6 Traditional Chinese Medicinal Materials

3.6.1 Resources

3.6.2 Price Trend

3.7 Plant Extract

3.7.1 Development Status

3.7.2 Import and Export

4. Chinese Patent Medicine Market Segments in China4.1 Overview 4.2 Chinese Patent Medicine for Cardiovascular and Cerebrovascular Diseases 4.3 Chinese Patent Medicine for Tumor Diseases 4.4 Chinese Patent Medicine for Respiratory System Diseases 4.5 Chinese Patent Medicine for Musculoskeletal Diseases

5. Key Producers of Chinese Patent Medicine

5.1 Tianjin Tasly Pharmaceutical Co., Ltd.

5.1.1 Profile

5.1.2 Operation

5.1.3 Revenue Structure

5.1.4 Gross Margin

5.1.5 Development Prospect

5.2 Guizhou Yibai Pharmaceutical Co., Ltd.

5.2.1 Profile

5.2.2 Operation

5.2.3 Revenue Structure

5.2.4 Gross Margin

5.2.5 Development Prospect

5.3 Yunnan Baiyao Group Co., Ltd.

5.3.1 Profile

5.3.2 Operation

5.3.3 Revenue Structure

5.3.4 Gross Margin

5.3.5 Development Prospect

5.4 Zhangzhou Pientzehuang Pharmaceutical Co., Ltd.

5.4.1 Profile

5.4.2 Operation

5.4.3 Revenue Structure

5.4.4 Gross Margin

5.4.5 Development Prospect

5.5 Shandong Dong-E E-Jiao Co., Ltd.

5.5.1 Profile

5.5.2 Operation

5.5.3 Revenue Structure

5.5.4 Gross Margin

5.5.5 Development Prospect

5.6 China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (CR Sanjiu)

5.6.1 Profile

5.6.2 Operation

5.6.3 Revenue Structure

5.6.4 Gross Margin

5.6.5 Development Prospect

5.7 Shanghai Kaibao Pharmaceutical Co., Ltd.

5.7.1 Profile

5.7.2 Operation

5.7.3 Revenue Structure

5.7.4 Gross Margin

5.7.5 Development Prospect

5.8 Kangmei Pharmaceutical Co., Ltd.

5.8.1 Profile

5.8.2 Operation

5.8.3 Revenue Structure

5.8.4 Gross Margin

5.8.5 Development Prospect

5.9 Tibet Rhodiola Pharmaceutical Holding Co., Ltd.

5.9.1 Profile

5.9.2 Operation

5.9.3 Revenue Structure

5.9.4 Gross Margin

5.9.5 Development Prospect

5.10 Beijing Tongrentang Co., Ltd. (TRT)

5.10.1 Profile

5.10.2 Operation

5.10.3 Revenue Structure

5.10.4 Gross Margin

5.10.5 Development Prospect

Selected Charts

Classification of Chinese Patent Medicine by Dosage Form

Classification of Chinese Patent Medicine by Pharmacology

Chinese Patent Medicine Industry Chain

Chinese Patent Medicine-related National Policies

Number of Chinese Patent Medicine Enterprises in China, 2008-2012

Revenue and YoY Growth Rate of Chinese Patent Medicine Industry in China, 2008-2012

Total Profit and YoY Growth Rate of Chinese Patent Medicine Industry in China, 2008-2012

Gross Margin of Chinese Patent Medicine Enterprises in China, 2011-2012

Output and YoY Growth Rate of Chinese Patent Medicine in China, 2008-2012

Output of Top 10 Chinese Patent Medicine Producing Regions in China, 2012

Sales of Top 10 Chinese Patent Medicine Sales Regions in China, 2011

Sales Structure of Top 10 Chinese Patent Medicine Sales Regions in China, 2011

Top 10 Chinese Provinces/Municipalities by Number of Above-scale Chinese Patent Medicine Enterprises, 2012

Top 10 Chinese Provinces/Municipalities by Sales of Chinese Patent Medicine Enterprises, 2012

Top 10 Chinese Provinces/Municipalities by Total Profit of Chinese Patent Medicine Enterprises, 2012

Chinese Provinces/Municipalities with Gross Margin of Chinese Patent Medicine Enterprises Above 40%, 2012

Number of Enterprises, Sales and Total Profit of China's Chinese Patent Medicine Market by Region, 2012

China's Chinese Patent Medicine Export Volume and YoY Growth Rate, 2008-2012

China's Chinese Patent Medicine Export Value and YoY Growth Rate, 2008-2012

China's Chinese Patent Medicine Export Destinations, Export Value and Products, 2012

China's Chinese Patent Medicine Export Destination Structure by Export Value, 2012

China's Chinese Patent Medicine Export Products, Export Volume and Export Destinations, 2012

China's Top 10 Chinese Patent Medicine Export Enterprises, 2011

China's Top 5 Chinese Patent Medicine Export Enterprises, 2012

China's Chinese Patent Medicine Import Value and YoY Growth Rate, 2008-2012

Revenue and Share in Pharmaceutical Industry of China's Chinese Patent Medicine Industry, 2008-2012

China's Population Aged 65 and Above, 2002-2012

Per Capita Healthcare Expenditure of China's Urban and Rural Residents, 2001-2011

China's Number of Hospitals and CAGR, 2001-2011

China's Panax Notoginseng Price, 2008-2012

Trend Chart of Traditional Chinese Medicinal Material Comprehensive 200 Index, 2007-2012

Price Index of Traditional Chinese Medicinal Materials in Chengdu, China, 2010-2012

Major Traditional Chinese Medicinal Material GAP Enterprises in China, 2012

China's Plant Extract Import and Export Value, 2008-2012

China's Plant Extract Export Destination Structure by Export Value, 2012

Share of Chinese Patent Medicine in the Medicine Sold to Hospitals in China by Disease, 2011

Four Major Types of Chinese Patent Medicine for Cardiovascular and Cerebrovascular Diseases

Share of Chinese Patent Medicine for Cardiovascular and Cerebrovascular Diseases in the Chinese Patent Medicine Sold to Hospitals in China, 2007-2011

Excellent Brands of Chinese Patent Medicine for Cardiovascular and Cerebrovascular Diseases, 2012

Share of Chinese Patent Medicine for Tumor Diseases in the Chinese Patent Medicine Sold to Hospitals in China, 2007-2011

Top 10 Excellent Brands of Chinese Patent Medicine for Tumor Diseases in China, 2012

Share of Chinese Patent Medicine for Respiratory System Diseases in the Chinese Patent Medicine Sold to Hospitals in China, 2007-2011

Chinese Patent Medicine for Respiratory System Diseases in Sample Hospital by Type, 2009

Excellent Brands of Chinese Patent Medicine for Respiratory System Diseases, 2012

Share of Chinese Patent Medicine for Musculoskeletal Diseases in the Chinese Patent Medicine Sold to Hospitals in China, 2007-2011

China's Top 10 Excellent Brands of Traditional Chinese Medicine for Musculoskeletal Diseases, 2012

Revenue and YoY Growth Rate of Tasly, 2008-2012

Net Income and YoY Growth Rate of Tasly, 2008-2012

Revenue of Tasly by Sector, 2008-2012

Revenue of Tasly by Region, 2008-2012

Gross Margin of Tasly by Sector, 2008-2012

Gross Margin of Tasly by Region, 2009-2012

Revenue and Net Income of Tasly, 2011-2015

Revenue and YoY Growth Rate of Yibai Pharmaceutical, 2008-2012

Net Income and YoY Growth Rate of Yibai Pharmaceutical, 2008-2012

Revenue of Yibai Pharmaceutical by Sector, 2009-2012

Revenue of Yibai Pharmaceutical by Product, 2008-2012

Revenue of Yibai Pharmaceutical by Region, 2008-2012

Gross Margin of Yibai Pharmaceutical by Sector, 2009-2012

Gross Margin of Yibai Pharmaceutical by Product, 2008-2012

Gross Margin of Yibai Pharmaceutical by Region, 2008-2012

Revenue and Net Income of Yibai Pharmaceutical, 2011-2015

Revenue and YoY Growth Rate of Yunnan Baiyao, 2008-2012

Net Income and YoY Growth Rate of Yunnan Baiyao, 2008-2012

Revenue of Yunnan Baiyao by Sector, 2008-2012

Revenue of Yunnan Baiyao by Product, 2009-2012

Revenue of Yunnan Baiyao by Region, 2008-2012

Gross Margin of Yunnan Baiyao by Sector, 2008-2012

Gross Margin of Yunnan Baiyao by Product, 2009-2012

Gross Margin of Yunnan Baiyao by Region, 2008-2012

Revenue and Net Income of Yunnan Baiyao, 2011-2015

Revenue and YoY Growth Rate of Pientzehuang, 2008-2012

Net Income and YoY Growth Rate of Pientzehuang, 2008-2012

Revenue of Pientzehuang by Sector, 2008-2012

Revenue of Pientzehuang by Region, 2008-2012

Gross Margin of Pientzehuang by Sector, 2008-2012

Gross Margin of Pientzehuang by Product, 2008-2012

Gross Margin of Pientzehuang by Region, 2008-2012

Revenue and Net Income of Pientzehuang, 2011-2015

Revenue and YoY Growth Rate of Dong-E E-Jiao, 2008-2012

Net Income and YoY Growth Rate of Dong-E E-Jiao, 2008-2012

Revenue of Dong-E E-Jiao by Product, 2008-2012

Revenue of Dong-E E-Jiao by Region, 2008-2012

Gross Margin of Dong-E E-Jiao by Product, 2008-2012

Gross Margin of Dong-E E-Jiao by Region, 2009-2012

Revenue and Net Income of Dong-E E-Jiao, 2011-2015

Revenue and YoY Growth Rate of CR Sanjiu, 2008-2012

Net Income and YoY Growth Rate of CR Sanjiu, 2008-2012

Revenue of CR Sanjiu by Sector, 2008-2012

Revenue of CR Sanjiu by Region, 2008-2012

Gross Margin of CR Sanjiu by Sector, 2008-2012

Revenue and Net Income of CR Sanjiu, 2011-2015

Revenue and YoY Growth Rate of Shanghai Kaibao, 2008-2012

Net Income and YoY Growth Rate of Shanghai Kaibao, 2008-2012

Revenue of Shanghai Kaibao by Product, 2008-2012

Revenue of Shanghai Kaibao by Region, 2008-2012

Gross Margin of Shanghai Kaibao by Product, 2008-2012

Revenue and Net Income of Shanghai Kaibao, 2011-2015

Revenue and YoY Growth Rate of Kangmei Pharmaceutical, 2008-2012

Net Income and YoY Growth Rate of Kangmei Pharmaceutical, 2008-2012

Revenue of Kangmei Pharmaceutical by Region, 2008-2012

Gross Margin of Kangmei Pharmaceutical by Region, 2008-2012

Revenue and Net Income of Kangmei Pharmaceutical, 2011-2015

Revenue and YoY Growth Rate of Tibet Rhodiola Pharmaceutical, 2008-2012

Net Income and YoY Growth Rate of Tibet Rhodiola Pharmaceutical, 2008-2012

Revenue of Tibet Rhodiola Pharmaceutical by Product, 2008-2012

Revenue of Tibet Rhodiola Pharmaceutical by Region, 2008-2012

Gross Margin of Tibet Rhodiola Pharmaceutical by Sector, 2008-2012

Gross Margin of Tibet Rhodiola Pharmaceutical by Product, 2008-2012

Gross Margin of Tibet Rhodiola Pharmaceutical by Region, 2008-2012

Revenue and Net Income of Tibet Rhodiola Pharmaceutical, 2011-2015

Revenue and YoY Growth Rate of Tongrentang, 2008-2012

Net Income and YoY Growth Rate of Tongrentang, 2008-2012

Revenue of Tongrentang by Region, 2008-2012

Gross Margin of Tongrentang by Region, 2009-2012

Revenue and Net Income of Tongrentang, 2011-2015

To order this report:Drug_and_Medication Industry: China Chinese Patent Medicine Industry Report, 2012-2015

Contact Clare: [email protected]
US:(339) 368 6001
Intl:+1 339 368 6001

SOURCE Reportlinker